News
SNS Insider Unveils Strategic Insights into the U.S. Long Read Sequencing Market's Exponential Growth-Valued at USD 220.26 Million in 2023-While the ...
StockStory.org on MSN17d
Q1 Earnings Roundup: PacBio (NASDAQ:PACB) And The Rest Of The Life Sciences Tools & Services SegmentAs the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...
June 26, 2025, is the 25th anniversary of the White House announcement of the first sequencing of the human genome, and July 28, 2025, marks the 30th anniversary of the publication of the first ...
About Pacific Biosciences of California Inc. Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis.
Pacific Biosciences of California faces steep stock decline and financial challenges. Click here to see why PACB stock is a Sell.
access to the Data Engine is open to scientists worldwide at no cost. Whole genomes from this initiative are already available to be mined and analyzed. Together, Target ALS and PacBio continue to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results